Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:41 p.m.

    📋 MADRIGAL PHARMACEUTICALS, INC. (MDGL) - Financial Results

    Filing Date: 2022-08-04

    Accepted: 2022-08-04 06:33:03

    Event Type: Financial Results

    Event Details:

    Madrigal Pharmaceuticals Inc (MDGL) Reports Q3 2022 Financial Results Madrigal Pharmaceuticals Inc (MDGL) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 211766

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Loss From Operations 61.74K 127.86K $-66.12K -51.71%
    Interest Expense 780.00 780.00 $0.00 +0.00%
    Net Loss 61.65K 128.25K $-66.60K -51.93%
    Assets Cash Equivalents Marketable Securities 211.77K 270.35K $-58.58K -21.67%
    Loss from Operations 70.27K 61.74K $8.53K +13.82%
    Interest Income 323.00 91.00 $232.00 +254.95%
    Net Loss 70.73K 61.65K $9.08K +14.73%
    Cash and Marketable Securities 211.77K 270.35K $-58.58K -21.67%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Madrigal Pharmaceuticals Inc
    • CIK: 0001157601
    • Ticker Symbol: MDGL
    • Period End Date: 2022-08-04
    • Document Type: 8-K

Search

News categories